In this study, performed in non-diabetic volunteers during an intravenous glucose load, GLP-1 greatly enhanced insulin release, reduced glucagon concentrations and significantly reduced peak plasma glucose concentrations, compared with a control saline infusion
Where it works: Adipose tissue (fat cells): Reduces inflammation and may improve fat metabolism Pancreas: Works alongside GLP-1 to enhance insulin secretion Brain: May contribute to appetite regulation (research ongoing) Weight loss contribution: When GIP is added to GLP-1 (as in tirzepatide), weight loss increases from ~15% to ~22%
NICE recommends regular review of weight loss progress, with consideration of treatment discontinuation if less than 5% body weight loss is achieved after 6 months at maintenance dose
It feels really good to lose this much weight, especially because I never thought I could. Learn more about LifeMD and Triple Therapy here
If you're considering weight management options and glutathione vs tirzepatide is on your radar, the decision tree is straightforward: glutathione is appropriate for oxidative stress support, liver enzyme management, and general antioxidant defense
Peptides are not inherently good or bad